期刊文献+

抗菌药物致肝脏毒性的研究进展 被引量:2

Research Progress of Antimicrobial Agents Induced Hepatotoxicity
下载PDF
导出
摘要 药物性肝损伤(DILI)是指各类药物及其代谢产物和辅料等所诱发的肝损伤,是临床药源性疾病之一。在DILI相关研究中,抗菌药物是最为常见的药物类型。随着抗菌药物在临床上日益广泛应用,抗菌药物相关性肝损伤事件发生也不断增加,严重时可危及生命。本文通过对不同类型抗菌药物致肝脏毒性的机制及临床特点等相关研究进行综述,旨在深入了解抗菌药物致肝脏毒性的机制,为加强抗菌药物致肝损伤的防治及临床安全合理应用提供参考。 Drug-induced liver injury(DILI) is a clinical drug-induced disease induced by various drugs and drug metabolites and excipients. In DILI related studies, antibacterial drugs are the most common type of drugs.With the increasing use of antibacterial drugs in clinical practice, the incidence of liver injury related to antibacterial drugs is also increasing, which can endanger life in serious cases. This article reviews the mechanism and clinical characteristics of liver toxicity caused by different types of antibacterial drugs, aiming to deeply understand the mechanism of liver toxicity caused by antibacterial drugs, and provide reference for strengthening the prevention and treatment of liver injury caused by antibacterial drugs and clinical safe and reasonable application.
作者 凌亚豪 廖乐乐 靳洪涛 时涛 Ling Ya-hao;Liao Le-le;Jin Hong-tao;Shi Tao(Department Department of Pharmacy,People's Hospital of Longhua,Shenzhen 518109;New Drug Safety Evaluation Center,Institute of Materia Medica,Chinese Academy of Medical Sciences,Beijing 100050;Beijing Union-Genius Pharmaceutical Technology Development Co.,Ltd.,Beying 100176)
出处 《国外医药(抗生素分册)》 CAS 2023年第1期39-44,共6页 World Notes on Antibiotics
基金 深圳市龙华区医疗卫生机构区级科研项目(2022106) 中国毒理学会临床毒理专项资助课题(CST2021CT101)。
关键词 抗菌药物 肝脏毒性 发病机制 合理用药 药物性肝损伤 研究进展 antimicrobial agents liver toxicity pathogenesis rational drug use drug-induced liver injury research progress
  • 相关文献

参考文献4

二级参考文献6

共引文献118

同被引文献31

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部